Transcatheter Aortic Valve Implantation Market held USD 3.44 billion in 2019 and is predicted to reach USD 16.16 billion by 2030 with a CAGR of 15.1%

Transcatheter aortic valve implantation (TAVI) is used in patients who are elderly or are at high risk for surgery and have severe symptomatic aortic valve stenosis. A heart valve is present in arteries and veins and enables blood flow only in one direction through the heart. TAVI is also called transcatheter aortic valve replacement (TAVR) is a minimally invasive surgical procedure that is performed to treat high-risk patients suffering from aortic stenosis.

Access Full Description of this report at:-

https://www.nextmsc.com/report/transcatheter-aortic-valve-implantation-market

Top Companies: JC Medical, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG, Venus Medtech, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Abbott Laboratories, Boston Scientific Corporation, BraccoS.p.A and others.

The heart valve is the most widespread disease among the population aged above 65 years. Around 5% of the global population aged above 65 years is at the risk of emerging heart valve diseases. The TAVI includes implantation of the specially designed transcatheter aortic valve that can regenerate the blood pumping function of the heart’s aortic valve.

The factors including increased prevalence of aortic stenosis coupled with the increase in geriatric population, increase in adoption rate for the transcatheter aortic valve implantation procedure, an increase in the number of TAVR centers has majorly driven the transcatheter aortic valve implantation market. Furthermore, an increase in clinical evidence of safety and efficacy and new device approvals has led to a rising in the demand of transcatheter aortic valve implantation (TAVI). However, the high cost of the device and unfavorable reimbursement policies and stringent regulatory approval process is hampering the growth of the transcatheter aortic valve implantation market. The use of TAVI systems for new indications and rising healthcare expenditure of developing countries will create new opportunities for the market growth in the future.

Request sample copy of this report at:-

https://www.nextmsc.com/Transcatheter-Aortic-Valve-Implantation-Market/request-sample

The transcatheter aortic valve implantation market is segmented on the basis of procedure and geography. On the basis of procedure, the market covers transfemoral implantation, transapical implantation, and transaortic implantation. Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and ROW.

North America is anticipated to hold the highest transcatheter aortic valve implantation market share during the forecast period. This is attributable to the factors including enhanced developments in high consumer awareness, the introduction of transcatheter heart valve replacement, and technological advancements

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to improvement in public & private healthcare facility and high R&D investments.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.